Pharma News, 2025

HYDERABAD, Feb 25 (Reuters) - Indian drugmakers are likely to remain competitive in the generics market even as U.S. President Donald Trump's plans to levy tariffs on pharmaceutical import...

Adtalem Global Education to Participate in Barclays 27th Annual Global Healthcare Conference

Diabetes Reversed in Islet Transplantation Preclinical Trial

Pharma West Africa To Explore Improving Access To Quality Medicines

Celltrion has secured marketing authorisation from the European Commission (EC) for Avtozma (CT-P47), a biosimilar to Chugai Pharmaceutical’s RoActemra (tocilizumab).

China Focus: Parkinson's possible to be blocked thanks to Chinese scientists' breakthrough research

The company has yet to secure a deal, after announcing plans to sign one with a big pharma company in August 2024. Nonetheless, CEO Adam Steensberg emphasised that Zealand is “exactly where it wants...

Boston Scientific Corporation Boston Scientific Corporation today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned finance subsidiary, has priced ...

FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).

CSL Behring KK has gained approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous (SC) injection 200mg Andembry (Garadacimab...